Brought to you by 
Addex gets CHF157.4mm via IPO
24 Jul 2007
Executive Summary
Addex Pharmaceuticals SA (developing therapeutics for neurological and gastrointestinal disorders) raised CHF157.4mm ($128.3m, including the overallotment) in its initial public offering of 2.16mm shares at CHF73 each.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com